Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/20/2008US20080287473 Novel molecules for regulating cell death
11/20/2008US20080287471 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
11/20/2008US20080287470 Presentation of an Antiviral Pharmaceutical Composition
11/20/2008US20080287469 Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation
11/20/2008US20080287468 Purine and imidazopyridine derivatives for immunosuppression
11/20/2008US20080287467 Therapeutic Agent for Respiratory Diseases
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287465 Cyclic N-Hydroxy Imides as Inhibitors of Flap Endonuclease and Uses Thereof
11/20/2008US20080287464 Depot Formulations
11/20/2008US20080287462 New compounds 834
11/20/2008US20080287461 5-Bromo-2,6-dimethyl-6'-{[4-(trifluoromethoxy)benzyl]oxy}-3,3'-bipyridin-4(1H)-one; 3-Chloro-2,6-dimethyl-5-(5-nonyl-2-pyrimidinyl)-4(1H)-pyridinone; treating maleria causerd by infection with Plasmodium falciparum
11/20/2008US20080287460 New compounds 835
11/20/2008US20080287459 Pharmaceutical Composition for Treating Hair Loss and Benign Prostatic Hyperplasia
11/20/2008US20080287458 Dihydroquinone and dihydronaphthridine inhibitors of JNK
11/20/2008US20080287457 Inhibitors of Akt Activity
11/20/2008US20080287456 Oral Therapeutic Compound Delivery System
11/20/2008US20080287455 Sulfanyl substituted phenyl methanones
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287453 Piperazine Compounds Useful as Antagonists of C-C Chemokines (Ccr2b and Ccr5) for the Treatment of Inflammatory Diseases
11/20/2008US20080287452 Heteroaryl/aryl pyrimidine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
11/20/2008US20080287451 Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
11/20/2008US20080287450 Novel Substituted Tetracyclic Tetahydrofuran, Pyrrolidine And Tetrahydrothiophene Derivatives
11/20/2008US20080287449 Aza-tripeptide hepatitis c serine protease inhibitors
11/20/2008US20080287448 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/20/2008US20080287447 Methods for preparing eszopiclone
11/20/2008US20080287446 Sulfonyl Containing Compounds as Cysteine Protease Inhibitors
11/20/2008US20080287445 Prokineticin 2 receptor antagonists
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287443 Treatment of Subgingival Pocket Infections
11/20/2008US20080287442 Organic Compounds
11/20/2008US20080287441 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
11/20/2008US20080287440 Novel Antifungal Triazole Derivatives
11/20/2008US20080287439 Pyrimidine compounds
11/20/2008US20080287438 Agent for preventing or treating neuropathy
11/20/2008US20080287437 Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors
11/20/2008US20080287436 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
11/20/2008US20080287434 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/20/2008US20080287433 derivatives of artemisinin, and their uses in the treatment of malaria
11/20/2008US20080287432 6H-1-Thia-5,6-diaza-as-indacene-2-carboxylic acid [3-(3-trifluoromethyl-phenylcarbamoyl)-phenyl]-amide; treatment of kinase-associated diseases
11/20/2008US20080287431 Heterocyclic Compound and Anti-Malignant-Tumor Agent Containing the Same as Active Ingredient
11/20/2008US20080287430 Furan Compounds Useful As Ep1 Receptor Antagonists
11/20/2008US20080287429 Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts
11/20/2008US20080287428 Novel Heterocyclidene Acetamide Derivative
11/20/2008US20080287427 Bicyclic Amides as Kinase Inhibitors
11/20/2008US20080287424 e.g. N-[amino(imino)methyl]-2-[2-(4-phenoxyphenyl)-5-phenyl-1H-pyrrol-1-yl]acetamide; beta -amyloid deposits and neurofibrillary tangles; cognition activator, neurodegenerative diseases; Alzheimer's disease, Down's syndrome
11/20/2008US20080287423 Antidiabetic agents; neurodegenerative disorders; mixture with immunosuppresants
11/20/2008US20080287422 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide (CGRP) receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma
11/20/2008US20080287421 3,3-spiroindolinone derivatives
11/20/2008US20080287420 Cyclopamine lactam analogs and methods of use thereof
11/20/2008US20080287419 Apoptosis promoters
11/20/2008US20080287418 Extended Release Compositions and Methods for Their Manufacture
11/20/2008US20080287417 Pharmaceutical compositions comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
11/20/2008US20080287416 Organic Compounds
11/20/2008US20080287415 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
11/20/2008US20080287414 Mitotic Kinesin Inhibitors
11/20/2008US20080287413 New crystalline forms
11/20/2008US20080287412 Therapeutic combination of amlodipine and benazepril/benazeprilat
11/20/2008US20080287411 Optically active dihydropyridine derivative
11/20/2008US20080287410 Pyrimidine derivatives useful as inhibitors of pkc-theta
11/20/2008US20080287409 Phenyl and pyridinyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceutical compositions
11/20/2008US20080287408 Endometriosis treatment
11/20/2008US20080287407 Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
11/20/2008US20080287406 Compositions and methods for treating medical conditions
11/20/2008US20080287405 Compositions and Methods Relating to Protein Kinase Inhibitors
11/20/2008US20080287404 High Purity 17Alpha-Cyanomethyl-17Beta-Hydroxy-Estra-4,9-Diene-3- One and Process For the Syntheses Thereof
11/20/2008US20080287403 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
11/20/2008US20080287402 Use of a glial attenuator to prevent amplified pain responses caused by glial priming
11/20/2008US20080287401 Methods for Synthesizing and Purifying Aminoalkyl Tetracycline Compounds
11/20/2008US20080287400 Comprising risedronate, a chelating agent, and, means for effecting delayed release of the risedronate and the chelating agent in the small intestine; enteric coating
11/20/2008US20080287399 Substituted Aminopyridines and Uses Thereof
11/20/2008US20080287398 Cold menthol receptor-1 antagonists
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
11/20/2008US20080287396 Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections
11/20/2008US20080287395 Phospholipid Compositions for Contact Lens Care and Preservation of Pharmaceutical Compositions
11/20/2008US20080287394 hydroxy-substituted pyrazinopyrrolopyridazine dione compounds; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(2-fluorobenzyl)-10-hydroxy-4,8-dimethyl-7,8-dihydropyrazino[1',2':1,5]-pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-dione
11/20/2008US20080287393 External Skin Composition
11/20/2008US20080287392 Wound-Healing Pharmaceutical Compositions in the Form of a Cream Based on Amino Acids and Sodium Hyaluronate
11/20/2008US20080287391 Cell Fusion Promoter and Utilization of the Same
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080287389 Nucleoside analogs in combination therapy of herpes simplex infections
11/20/2008US20080287388 Human G-Protein Coupled Receptor
11/20/2008US20080287387 Method for Producing Sterile Polynucleotide Based Medicaments
11/20/2008US20080287386 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287384 Methods of Identifying Agents Having Antiangiogenic Activity
11/20/2008US20080287383 Nucleic acid compounds for inhibiting erbb gene expression and uses thereof
11/20/2008US20080287382 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
11/20/2008US20080287381 Injectable Agent for the Targeted Treatment of Retinal Ganglion Cells
11/20/2008US20080287380 Antisense Oligonucleotides Against Cpla2, Compositions and Uses Thereof
11/20/2008US20080287379 Oligonucleotide Complex Compositions and Methods of Use as Gene Alteration Tools
11/20/2008US20080287378 Solid state forms of 5-azacytidine and processes for preparation thereof
11/20/2008US20080287377 Composition Based on Triethyl Citrate for the Prevention of Enzymatic Hydrolysis of Triglycerides
11/20/2008US20080287376 Ketolide Derivatives as Antibacterial Agents
11/20/2008US20080287375 Selective Glycosidase Inhibitors, Methods of Making Inhibitors, and Uses Thereof
11/20/2008US20080287374 Breast cancer-resistant protein inhibitor
11/20/2008US20080287373 Topical skin treating kits
11/20/2008US20080287372 Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment
11/20/2008US20080287370 Boronic Acid Salts Useful in Parenteral Formulations
11/20/2008US20080287368 Methods and Compositions For the Prevention and Treatment of Kidney Disease
11/20/2008US20080287366 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
1 ... 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 ... 7860